It is a comparison between a combination of Bilastine with Montelukast and Fexofenadine with Montelukast in Allergic Rhinitis.
Not Applicable
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2022/11/047305
- Lead Sponsor
- ROHILKHAND MEDICAL COLLEGE AND HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients willing to participate in this study. All patients including both the gender above the age of 18 years. All cases having symptom of Allergic Rhinitis.
Exclusion Criteria
Female patients during Pregnancy and Lactation. Patients with Hypertensive Heart Disease, Diabetes Mellitus, Throid Dysfunction. Patients with nasal mass. Patients with past history of nasal surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of Bilastine with Montelukast and Fexofenadine with Montelukast in the treatment of Allergic Rhinitis.Timepoint: 0, 2 and 4 weeks
- Secondary Outcome Measures
Name Time Method Symptom free duration.Timepoint: 0, 2 and 4 weeks